The influence of blood pressure on intracellular Ca2+ content in erythrocytes: Effects of cadmium chloride and nifedipine

Clinical and Experimental Hypertension

Volumn 18, Issue 1, 1996, Pages 77-86

  Erkiliç, Asli Baykal ^a   Isbir, Mehmet ^a   Özdem, Sadi ^a   Öǧütman, Çaǧlar ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

CdCl2; Fura 2AM; Nifedipine; Spectrofluorophotometer

Indexed keywords

CADMIUM CHLORIDE; NIFEDIPINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE; HYPERTENSION; MALE; NONHUMAN; PATHOGENESIS; RAT;

ANIMALS; BLOOD PRESSURE; CADMIUM CHLORIDE; CALCIUM; CALCIUM CHANNEL BLOCKERS; CYTOSOL; ERYTHROCYTES; HYPERTENSION; MALE; NIFEDIPINE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 0029926746     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969609082608     Document Type: Article

References (20)

1. 2+ indicator fura-2. Cell Calcium 1988; 9:167-179.
2. Tsien RY, Poenie M. Fluorescence ratio imaging: a new window into intracellular ionic signalling. TIBS 1986; 11: 450-455.
3. Oshima T, Young EW, Hermsmeyer K, McCarron DA. Modification of platelet and lymphocyte calcium handling and blood pressure by dietary sodium and calcium in genetically hypertensive rats. J Lab Clin Med 1992; 119: 151-158.
4. Schrier SL, Johnson MJI, Krueger J. Calcium distribution within human erythrocytes. Biood 1980; 56: 667-676.
5. 2+ content of human erythrocytes. Cell Calcium 1986; 7: 169-174.
6. Zidek W, Loss H, Dorst KG, Zumkley H, Vetter H. Intracellular sodium and calcium in essential hypertension. Klin Wochenschr 1982; 60: 859-862.
7. 2+ concentration in essential hypertension. Hypertension 1992; 19: 167-74.
8. Cobbold PH, Rink TJ. Fluorescence and bioluminescence measurement of cytoplasmic free calcium Biochem J 1987: 248: 313-328.
9. Wickham NWR, Vercelotti GM, Moldow CF, Visser MR, Jacob HS. Measurement of intracellular calcium concentration in intact monolayers of human endothetial cells. J lab Clin Med 1988; 112: 157-167.
10. Giridhar J, Isom GE. Alteration of atrial natriuretic peptide levels by short term cadmium treatment. Toxicology 1991, 70: 185,94.1
11. Criscione L, Nellis P, Rinikier B, Thomann H, Burdet R. Reactivity and sensitivity of mesenteric vascular beds and aortic rings of spontaneously hypertensive rats to endothelin. Br J Pharmacol 1990; 99: 31-36.
12. Goodman AG, Rall TW, Nies AS, Taylor P. The Pharmacological Basis of Therapeutics. New York: Macmillan Publishing Corporation, 1990; 774-780.
13. Bolger GT, Liard F, Jodoin A, Jaramillo J. Vascular reactivity, tissue levels, and binding sites for endothelin. Can J Physiol Pharmacol 1990; 69: 406-413.
14. Caimi G, Presti RL, Serra A, Grifo G, Sarno A. Red cell calcium content and erythrocyte membrane fluidity in vascular atherosclerotic disease. Clin Hemorheol 1991; 11: 617-621.
15. Balaraman R, Gulati OD, Bhatt JD, Rathod SP, Hemavathi KG. Cadmium-induced hypertension in rats. Pharmacology 1989; 38: 226-234.
16. Hall CE, Hungerford S. Influence of dosage consciousness and nifedipine on the acute presser response to intraperitoneally administered cadmium. J Toxicol Envir Health 1982; 9:953-961.
17. Kostyuk PG. Calcium ionic channels in electrically excitable membrane. Neuroscience 1980; 5: 945-959.
18. Blaustein MP Sodium ions, calcium ions, blood pressure regulation and hypertension. Am J Physiol 1977; 232: C165-C172.
19. Vincenzi FF, Morris CD, Kinsel LB. Decreased calcium pump adenosine triphosphatase in red blood cells of hypertensive subjects. Hypertension 1986; 8: 1058-1066.
20. Stimpel M, Neyses L, Locher R, Groth H, Vetter W Human red blood cells- an ideal model system for the action of calcium agonists and antagonists. J Hypertension Suppl. 1984; 2: S577-580.